These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 33939330)
1. Ketogenic diet treatment in diffuse intrinsic pontine glioma in children: Retrospective analysis of feasibility, safety, and survival data. Perez A; van der Louw E; Nathan J; El-Ayadi M; Golay H; Korff C; Ansari M; Catsman-Berrevoets C; von Bueren AO Cancer Rep (Hoboken); 2021 Oct; 4(5):e1383. PubMed ID: 33939330 [TBL] [Abstract][Full Text] [Related]
2. Ketogenic diet treatment in recurrent diffuse intrinsic pontine glioma in children: A safety and feasibility study. van der Louw EJTM; Reddingius RE; Olieman JF; Neuteboom RF; Catsman-Berrevoets CE Pediatr Blood Cancer; 2019 Mar; 66(3):e27561. PubMed ID: 30484948 [TBL] [Abstract][Full Text] [Related]
3. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG). DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839 [TBL] [Abstract][Full Text] [Related]
4. Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC). Fonseca A; Afzal S; Bowes L; Crooks B; Larouche V; Jabado N; Perreault S; Johnston DL; Zelcer S; Fleming A; Scheinemann K; Silva M; Vanan MI; Mpofu C; Wilson B; Eisenstat DD; Lafay-Cousin L; Hukin J; Hawkins C; Bartels U; Bouffet E J Neurooncol; 2020 Aug; 149(1):45-54. PubMed ID: 32632896 [TBL] [Abstract][Full Text] [Related]
5. Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG. Chiang J; Diaz AK; Makepeace L; Li X; Han Y; Li Y; Klimo P; Boop FA; Baker SJ; Gajjar A; Merchant TE; Ellison DW; Broniscer A; Patay Z; Tinkle CL Acta Neuropathol Commun; 2020 Apr; 8(1):57. PubMed ID: 32326973 [TBL] [Abstract][Full Text] [Related]
6. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma. Gállego Pérez-Larraya J; Garcia-Moure M; Labiano S; Patiño-García A; Dobbs J; Gonzalez-Huarriz M; Zalacain M; Marrodan L; Martinez-Velez N; Puigdelloses M; Laspidea V; Astigarraga I; Lopez-Ibor B; Cruz O; Oscoz Lizarbe M; Hervas-Stubbs S; Alkorta-Aranburu G; Tamayo I; Tavira B; Hernandez-Alcoceba R; Jones C; Dharmadhikari G; Ruiz-Moreno C; Stunnenberg H; Hulleman E; van der Lugt J; Idoate MÁ; Diez-Valle R; Esparragosa Vázquez I; Villalba M; de Andrea C; Núñez-Córdoba JM; Ewald B; Robbins J; Fueyo J; Gomez-Manzano C; Lang FF; Tejada S; Alonso MM N Engl J Med; 2022 Jun; 386(26):2471-2481. PubMed ID: 35767439 [TBL] [Abstract][Full Text] [Related]
7. A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma. Su JM; Murray JC; McNall-Knapp RY; Bowers DC; Shah S; Adesina AM; Paulino AC; Jo E; Mo Q; Baxter PA; Blaney SM Pediatr Blood Cancer; 2020 Jun; 67(6):e28283. PubMed ID: 32285998 [TBL] [Abstract][Full Text] [Related]
8. Influence of socioeconomic status on clinical outcomes of diffuse midline glioma and diffuse intrinsic pontine glioma. Lee JH; Holste KG; Bah MG; Franson AT; Garton HJL; Maher CO; Muraszko KM J Neurosurg Pediatr; 2024 Jun; 33(6):507-515. PubMed ID: 38489807 [TBL] [Abstract][Full Text] [Related]
9. Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience. Crotty EE; Leary SES; Geyer JR; Olson JM; Millard NE; Sato AA; Ermoian RP; Cole BL; Lockwood CM; Paulson VA; Browd SR; Ellenbogen RG; Hauptman JS; Lee A; Ojemann JG; Vitanza NA J Neurooncol; 2020 Jul; 148(3):607-617. PubMed ID: 32556862 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. Lieberman NAP; DeGolier K; Kovar HM; Davis A; Hoglund V; Stevens J; Winter C; Deutsch G; Furlan SN; Vitanza NA; Leary SES; Crane CA Neuro Oncol; 2019 Jan; 21(1):83-94. PubMed ID: 30169876 [TBL] [Abstract][Full Text] [Related]
11. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group. Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497 [TBL] [Abstract][Full Text] [Related]
12. Survival and neurological outcomes after stereotactic biopsy of diffuse intrinsic pontine glioma: a systematic review. Dalmage M; LoPresti MA; Sarkar P; Ranganathan S; Abdelmageed S; Pagadala M; Shlobin NA; Lam S; DeCuypere M J Neurosurg Pediatr; 2023 Dec; 32(6):665-672. PubMed ID: 37724839 [TBL] [Abstract][Full Text] [Related]
13. Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience. Lassaletta A; Strother D; Laperriere N; Hukin J; Vanan MI; Goddard K; Lafay-Cousin L; Johnston DL; Zelcer S; Zapotocky M; Rajagopal R; Ramaswamy V; Hawkins C; Tabori U; Huang A; Bartels U; Bouffet E Pediatr Blood Cancer; 2018 Jun; 65(6):e26988. PubMed ID: 29369515 [TBL] [Abstract][Full Text] [Related]
15. MRI Patterns of Extrapontine Lesion Extension in Diffuse Intrinsic Pontine Gliomas. Makepeace L; Scoggins M; Mitrea B; Li Y; Edwards A; Tinkle CL; Hwang S; Gajjar A; Patay Z AJNR Am J Neuroradiol; 2020 Feb; 41(2):323-330. PubMed ID: 31974084 [TBL] [Abstract][Full Text] [Related]
16. Correlation of multimodal Morana G; Tortora D; Bottoni G; Puntoni M; Piatelli G; Garibotto F; Barra S; Giannelli F; Cistaro A; Severino M; Verrico A; Milanaccio C; Massimino M; Garrè ML; Rossi A; Piccardo A Theranostics; 2020; 10(26):11881-11891. PubMed ID: 33204317 [TBL] [Abstract][Full Text] [Related]
17. [Formula: see text] The neuropsychological profile of children with Diffuse Intrinsic Pontine Glioma (DIPG) before and after radiation therapy: A prospective longitudinal study. Rhodes A; Martin S; Toledo-Tamula MA; Loucas C; Glod J; Warren KE; Wolters PL Child Neuropsychol; 2023 Aug; 29(6):934-958. PubMed ID: 36369715 [TBL] [Abstract][Full Text] [Related]
18. Suggestions for Escaping the Dark Ages for Pediatric Diffuse Intrinsic Pontine Glioma Treated with Radiotherapy: Analysis of Prognostic Factors from the National Multicenter Study. Kim HJ; Lee JH; Kim Y; Lim DH; Park SH; Ahn SD; Kim IA; Im JH; Chung JW; Kim JY; Kim IH; Yoon HI; Suh CO Cancer Res Treat; 2023 Jan; 55(1):41-49. PubMed ID: 35255651 [TBL] [Abstract][Full Text] [Related]
19. The relationship between imaging features, therapeutic response, and overall survival in pediatric diffuse intrinsic pontine glioma. Yu X; Lai M; Li J; Wang L; Ye K; Zhang D; Hu Q; Li S; Hu X; Wang Q; Ma M; Xiao Z; Zhou J; Shi C; Luo L; Cai L Neurosurg Rev; 2024 May; 47(1):212. PubMed ID: 38727935 [TBL] [Abstract][Full Text] [Related]
20. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas. Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]